Rapport Therapeutics Inc (RAPP) returns
$25.05 +3.47% Close Oct 30, 2026 Live
Rapport Therapeutics returns over 1 year
$1,000 invested in Rapport Therapeutics one year ago was worth $931.92 at the close on October 30, 2026, with dividends reinvested. The same $1,000 in the S&P 500 (SPY) became $1,124.
RAPP, $10,000 investedS&P 500 (SPY)
$10,000$20,000
20252026
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -25.4% | — | $745.54 | -0.9% |
| 3 months | -41.4% | — | $585.55 | +2.1% |
| Year to date | -17.4% | — | $825.64 | +11.7% |
| 1 year | -6.8% | — | $931.92 | +12.4% |
Rapport Therapeutics return by calendar year
| Year | RAPP | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -17.4% | +11.7% | -29.1% |
| 2025 | +71.0% | +17.7% | +53.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Rapport Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.